Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line
Yield10 Bioscience, Inc. (YTEN)
US:NASDAQ Investor Relations:
ir.yield10bio.com/investor-relations
Company Research
Source: GlobeNewswire
WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has received a positive response from USDA-APHIS’s Biotechnology Regulatory Services (BRS) confirming that its genome-edited Camelina sativa plant line developed using CRISPR genome editing technology for increased oil content does not meet the definition of a regulated article under 7 CFR Part 340 biotechnology regulations. In June 2017, Yield10 submitted its first “Am I Regulated?” letter to the BRS, which requested confirmation of the regulatory status for the novel plant line with an edit in the gene for the C3008 trait. The Company’s submission along with the APHIS BRS response is posted on the USDA’s web site. “Obtaining nonregulated status from USDA-APHIS for our genome-edited Camelina designed for enhanced oil content represents an important milestone for our team,” commented Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. “This designation high
Show less
Read more
Impact Snapshot
Event Time:
YTEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
YTEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
YTEN alerts
High impacting Yield10 Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
YTEN
News
- Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswire
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 [Yahoo! Finance]Yahoo! Finance
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024GlobeNewswire
YTEN
Earnings
- 11/14/23 - Miss
YTEN
Sec Filings
- 4/25/24 - Form S-1
- 4/19/24 - Form PRE
- 4/4/24 - Form DEF
- YTEN's page on the SEC website